首頁 > 市場調查報告書 > 醫療設備

整形外科

肱骨外上髁炎治療市場規模、佔有率、成長分析（按治療類型、最終用戶和地區）- 產業預測（2025 年至 2032 年）

市場調查報告書

商品編碼

1789241

肱骨外上髁炎治療市場規模、佔有率、成長分析（按治療類型、最終用戶和地區）- 產業預測（2025 年至 2032 年）

Lateral Epicondylitis Treatment Market Size, Share, and Growth Analysis, By Treatment Type (Non-Surgical Treatments, Surgical Treatments), By End User (Hospitals, Specialty Clinics), By Region - Industry Forecast 2025-2032

出版日期: 2025年08月07日 | 出版商:

SkyQuest | 英文 172 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

全球肱骨外上髁炎治療市場預計在 2023 年價值 12 億美元，從 2024 年的 12.5 億美元成長到 2032 年的 17.4 億美元，預計在預測期內（2025-2032 年）的複合年成長率為 4.2%。

由於患有重複性勞損的人數不斷增加，尤其是運動員、體力勞動者和上班族，全球肱骨外上髁炎治療市場正在經歷顯著成長。 PRP注射和衝擊波療法等微創治療方案的日益普及，以及預防措施意識的不斷增強，正在擴大治療的可及性。此外，再生醫學的進步，加上門診手術中心的激增，正在擴大患者的治療選擇。老年人口的不斷成長以及對早期療育重要性的日益重視，進一步促進了市場的擴張，為全球肱骨外上髁炎治療方案創造了一個強勁的環境。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲國家地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業市場定位（2024年）
主要市場參與者所採取的策略
近期市場趨勢
公司市場佔有率分析（2024年）
主要企業簡介
- 公司詳情
- 產品系列分析
- 按部門分類的公司佔有率分析
- 收益同比對比（2022-2024 年）

主要企業簡介

Teikoku Pharma, Inc.
Kasiak Research Pvt. Ltd.
Molecular Pharmacology Limited
Chugai Pharmaceutical Co., Ltd.
Seikagaku Corporation
OMRON Corporation
BioMedical Life Systems, Inc.
Zynex, Inc.
EMS Physio Ltd.
DJO Global, Inc.
Beurer GmbH
3M
AKSIGEN
BTL Corporate

結論和建議

簡介目錄

Product Code: SQMIG45N2126

Global Lateral Epicondylitis Treatment Market size was valued at USD 1.2 billion in 2023 and is poised to grow from USD 1.25 billion in 2024 to USD 1.74 billion by 2032, growing at a CAGR of 4.2% during the forecast period (2025-2032).

The global market for lateral epicondylitis treatment is experiencing significant growth driven by a rise in individuals affected by repetitive strain injuries, particularly among athletes, manual laborers, and office workers. The increasing availability of minimally invasive treatment options, such as PRP injections and shockwave therapy, along with heightened awareness of preventive measures, is enhancing treatment accessibility. Furthermore, advancements in regenerative medicine, coupled with the proliferation of ambulatory surgical centers, are broadening the options available for patients. The expanding elderly population and an increasing recognition of the importance of early intervention further contribute to the market's expansion, creating a robust landscape for lateral epicondylitis treatment solutions worldwide.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Lateral Epicondylitis Treatment market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Lateral Epicondylitis Treatment Market Segments Analysis

Global Lateral Epicondylitis Treatment Market is segmented by Treatment Type, End User and region. Based on Treatment Type, the market is segmented into Non-Surgical Treatments and Surgical Treatments. Based on End User, the market is segmented into Hospitals, Specialty Clinics, Ambulatory Surgical Centres and Homecare Settings. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Lateral Epicondylitis Treatment Market

The rising prevalence of lateral epicondylitis among various groups, including athletes, manual laborers, and office employees, significantly fuels the demand in the treatment market. This surge is largely attributed to the rise in repetitive motion activities across different occupations. Consequently, there is a heightened need for both non-surgical treatments, such as braces and physiotherapy, as well as surgical options like arthroscopic release. This trend is particularly pronounced in developed areas with aging populations who actively seek effective solutions for managing this condition. Overall, the broader awareness and recognition of lateral epicondylitis drive the market's growth trajectory.

Restraints in the Global Lateral Epicondylitis Treatment Market

Despite the efficacy of biologic treatments such as platelet-rich plasma and stem cell therapies, as well as shockwave therapy, their high costs combined with inconsistent insurance coverage-particularly in less developed regions-pose significant challenges. This financial hurdle restricts their widespread use and encourages healthcare providers and patients to turn to more affordable non-biologic options, such as corticosteroids. As a result, the market for Lateral Epicondylitis treatment is impacted, with a tendency to favor less expensive alternatives that may not offer the same long-term benefits, thus hindering the adoption of advanced therapeutic methods.

Market Trends of the Global Lateral Epicondylitis Treatment Market

The Global Lateral Epicondylitis Treatment market is witnessing a significant shift toward regenerative medicine, particularly with the increasing adoption of biologic therapies such as platelet-rich plasma therapy, stem cell injections, and growth factor-based treatments. These innovative therapies are gaining traction due to their potential to enhance natural tissue repair and reduce recurrence rates, appealing to both healthcare providers and patients seeking effective long-term solutions. This trend is especially pronounced in North America and Europe, where healthcare systems are increasingly supportive of these advanced treatment modalities, indicating a broader acceptance of biologics within traditional healthcare frameworks and driving market growth.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Case Studies
Customer Buying Behavior Analysis

Global Lateral Epicondylitis Treatment Market Size by Treatment Type & CAGR (2025-2032)

Market Overview
Non-Surgical Treatments
- Medications
- Physical therapy
- Orthotics and braces
- Other non-surgical treatments
Surgical Treatments
- Arthroscopic surgery
- Open surgery
- Other surgical treatments

Global Lateral Epicondylitis Treatment Market Size by Age Group & CAGR (2025-2032)

Market Overview
Pediatric
Adult
Geriatric

Global Lateral Epicondylitis Treatment Market Size by End User & CAGR (2025-2032)

Market Overview
Hospitals
Specialty Clinics
Ambulatory Surgical Centres
Homecare Settings

Global Lateral Epicondylitis Treatment Market Size & CAGR (2025-2032)

North America (Treatment Type, Age Group, End User)
- US
- Canada
Europe (Treatment Type, Age Group, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Treatment Type, Age Group, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Treatment Type, Age Group, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Treatment Type, Age Group, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

Teikoku Pharma, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Kasiak Research Pvt. Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Molecular Pharmacology Limited
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Chugai Pharmaceutical Co., Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Seikagaku Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
OMRON Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BioMedical Life Systems, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Zynex, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
EMS Physio Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
DJO Global, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Beurer GmbH
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
3M
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AKSIGEN
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BTL Corporate
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments